Ardelyx
Develops novel oral therapeutics to treat mineral metabolism and metabolic disorders.
Launch date
Employees
Market cap
AUD2.3b
Enterprise valuation
AUD2.2b (Public information from Sep 2024)
Share price
$5.99 ARDX
Fremont California (HQ)
Authorizing premium user...